Search results for "Cholesterol"
Preventive care still on during COVID-19
COVID-19 may foster innovation in primary care as physicians describe various strategies to reconnect with patients, such as leveraging telemedicine visits to also explain the practice's coronavirus-related safety protocols, or systematically reviewing their panels to flag at-risk patients.
https://immattersacp.org/archives/2020/11/preventive-care-still-on-during-covid-19.htm
1 Nov 2020
Aspirin associated with fewer CV events, more major bleeding in healthy patients, review finds
When weighing the risks and benefits of aspirin for primary cardiovascular (CV) prevention in individual patients, clinicians must also consider other interventions that may lower risk, an accompanying editorial said.
https://immattersacp.org/weekly/archives/2019/01/29/1.htm
29 Jan 2019
New assessment tool may improve predictions of CV risk, impact of preventive treatments
The new three-step tool aims to provide a framework for delivering appropriate risk-reducing strategies to Medicare patients with a 10-year atherosclerotic cardiovascular disease risk greater than 30%.
https://immattersacp.org/weekly/archives/2016/11/08/4.htm
8 Nov 2016
Restrictions on drug detailing may lead to less prescribing
Researchers looked at changes in prescribing behavior of 2,126 physicians at 19 academic medical centers in five states before and after enactment of detailing policies and compared them with those of 24,593 matched control physicians.
https://immattersacp.org/weekly/archives/2017/05/09/2.htm
9 May 2017
MKSAP Quiz: Cardiac risk assessment
A 58-year-old man is evaluated during a routine appointment and asks for advice on cardiac risk assessment. He does not have any current cardiac symptoms, exercises 4 days per week, and has never smoked. He has no chronic health issues and takes no medications. He has no known drug allergies. Results of the physical examination are normal. Following cardiovascular risk calculation, what test should be performed next?
https://immattersacp.org/weekly/archives/2016/04/05/3.htm
5 Apr 2016
Stopping preventive aspirin associated with 37% increased risk of cardiovascular events
Patients who continued aspirin had a 4.1% yearly incidence of cardiovascular events, compared to 5.4% among those who stopped taking the drug, while the risk of discontinuation corresponded to one additional cardiovascular event for every 74 patients who stopped taking aspirin in a year.
https://immattersacp.org/weekly/archives/2017/10/03/4.htm
3 Oct 2017
MKSAP Quiz: Evaluation of risk for cardiovascular disease
A 49-year-old man is evaluated during a routine examination. He is asymptomatic but is concerned about his risk for cardiovascular disease. Medical history is notable for hypertension. He is a nonsmoker, and he works as an executive at a highly successful company. Family history is noncontributory. His only medication is hydrochlorothiazide. Following a physical exam and cholesterol and glucose testing, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/02/09/3.htm
9 Feb 2016
Central obesity may increase mortality risk in those with normal BMI
Body mass index is limited as a sole measure of adiposity in clinical practice, in part because it makes no distinction between fat and lean mass, an editorial noted.
https://immattersacp.org/weekly/archives/2015/11/10/4.htm
10 Nov 2015
Exercise a fitting path to improved health
Some physicians tout successes in getting patients moving more by suggesting incremental changes in their activity levels, and also by highlighting the more immediately visible payoffs.
https://immattersacp.org/archives/2021/04/exercise-a-fitting-path-to-improved-health.htm
1 Apr 2021
Data support targeted approach to cholesterol screening in young adults
The 10-year risk for atherosclerotic cardiovascular disease was less than one half of 1% in nonsmoking, nondiabetic women younger than age 50 years and men younger than age 40 years.
https://immattersacp.org/weekly/archives/2017/05/16/1.htm
16 May 2017